4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-066398
Chairman and CEO bought 27,000 shares at an average $1.41 ($38,130)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-11-19 | Purchase | +15,000 | $1.39 | $20,850 | 10,934,147 | D |
| Niihara Yutaka Chairman and CEO | 2021-11-22 | Purchase | +12,000 | $1.44 | $17,280 | 10,946,147 | D |
| Open-market purchases · 27,000 sh · avg $1.41 · $38,130 | |||||||
Loading xslF345X03/doc4.xml…